Revenue from Q1 2011 primarily consisted of $6.5 million from sales of implants and disposables used in the 1,304 minimally invasive MAKOplasty knee procedures performed in the quarter. Additionally, approximately $5.3 million of Q1 revenue can be attributed to the sale and installation of seven RIO Robotic Arm Interactive Orthopedic systems, which is a surgical platform that supports MAKOplasty procedures.
Read the company news release about MAKO Surgical’s financial results (pdf).
Related Articles on Device Company Financial Results:
InVivo Therapeutics Reports $1.28M Net Loss in Q1
Bacterin Reports $6M in Q1 Revenue, 119% Increase
SANUWAVE Posts Q1 $252K Revenue, 76% Increase
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
